Fractyl Health to Report Fourth Quarter and Full Year 2024 Financial Results and Provide Business Updates on March 3, 2025

Company Overview - Fractyl Health, Inc. is a metabolic therapeutics company focused on innovative approaches for treating obesity and type 2 diabetes (T2D) [3] - The company aims to shift the treatment of metabolic diseases from chronic symptomatic management to durable disease-modifying therapies that address the root causes at the organ level [3] Upcoming Financial Results - Fractyl Health will report its financial results for the fourth quarter and full year 2024 on March 3, 2025, at 4:30 p.m. ET [1] - A live webcast of the conference call will be available in the "Events" section of Fractyl's website and will be archived for replay [2]